Specify a stock or a cryptocurrency in the search bar to get a summary
Changchun BCHT Biotechnology Co. A
688276Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company's products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China. Address: No. 138, Zhuoyue Street, Changchun, China, 130103
Analytics
WallStreet Target Price
311.43 CNYP/E ratio
27.74Dividend Yield
0.57 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688276
Dividend Analytics 688276
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
17 %Dividend History 688276
Stock Valuation 688276
Financials 688276
Results | 2019 | Dynamics |